trilostane has been researched along with indomethacin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Jungmann, E; Magnet, W; Rottmann-Kuhnke, U; Schöffling, K; Schwedes, U; Sprey, R; Usadel, KH | 1 |
Higuchi, K; Kominami, S; Takemori, S; Yamazaki, T | 1 |
Devaud, LL; Grobin, AC; Janis, GC; Matthews, DB; Morrow, AL; VanDoren, MJ | 1 |
Bridges, PJ; Ching, L; Kim, L; LeaMaster, BR; Vincent, DL; Weems, CW; Weems, YS | 1 |
Lewis, AW; Randel, RD; Weems, CW; Weems, YS | 1 |
Guo, C; Li, W; Ni, X; Sun, K; Zhu, P; Zhu, X | 1 |
7 other study(ies) available for trilostane and indomethacin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The inhibiting effect of trilostane on adrenal steroid synthesis: hormonal and morphological alterations induced by subchronic trilostane treatment in normal rats.
Topics: Adrenal Glands; Aldosterone; Animals; Corticosterone; Dihydrotestosterone; Indomethacin; Male; Organ Size; Potassium; Propranolol; Rats; Rats, Inbred Strains; Renin; Sodium | 1982 |
15-lipoxygenase metabolite(s) of arachidonic acid mediates adrenocorticotropin action in bovine adrenal steroidogenesis.
Topics: Animals; Arachidonate 15-Lipoxygenase; Arachidonic Acids; Benzoquinones; Bucladesine; Cattle; Cells, Cultured; Cosyntropin; Cyclic AMP; Dihydrotestosterone; Enzyme Inhibitors; Indomethacin; Isoquinolines; Kinetics; Leukotrienes; Lipid Peroxides; Lipoxygenase Inhibitors; Masoprocol; Pregnenolone; Sulfonamides; Tetrahydronaphthalenes; Zona Fasciculata; Zona Reticularis | 1996 |
Neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol.
Topics: Animals; Behavior, Animal; Bicuculline; Brain Chemistry; Central Nervous System Depressants; Cerebral Cortex; Convulsants; Cyclooxygenase Inhibitors; Dihydrotestosterone; Electrophysiology; Enzyme Inhibitors; Epilepsy; Ethanol; Finasteride; Indomethacin; Male; Neuroprotective Agents; Pregnanolone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2000 |
Effects of indomethacin, luteinizing hormone (LH), prostaglandin E2 (PGE2), trilostane, mifepristone, ethamoxytriphetol (MER-25) on secretion of prostaglandin E (PGE), prostaglandin F2alpha (PGF2alpha) and progesterone by ovine corpora lutea of pregnancy
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Corpus Luteum; Cyclooxygenase Inhibitors; Dihydrotestosterone; Dinoprost; Dinoprostone; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrus; Ethamoxytriphetol; Female; Hormone Antagonists; In Vitro Techniques; Indomethacin; Luteinizing Hormone; Mifepristone; Pregnancy; Progesterone; Prostaglandins E; Sheep | 2001 |
Effects of prostaglandins E2 and F2alpha (PGE2; PGF2alpha), trilostane, mifepristone, palmitic acid (PA), indomethacin (INDO), ethamoxytriphetol (MER-25), PGE2 + PA, or PGF2alpha + PA on PGE2, PGF2alpha, and progesterone secretion by bovine corpora lutea
Topics: Abortifacient Agents, Steroidal; Animals; Cattle; Corpus Luteum; Dihydrotestosterone; Dinoprost; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Estrogen Antagonists; Ethamoxytriphetol; Female; In Vitro Techniques; Indomethacin; Mifepristone; Oxytocics; Palmitic Acid; Pregnancy; Progesterone; Tocolytic Agents | 2002 |
Induction of progesterone receptor A form attenuates the induction of cytosolic phospholipase A2alpha expression by cortisol in human amnion fibroblasts.
Topics: Amnion; Cells, Cultured; Cyclooxygenase Inhibitors; Dihydrotestosterone; Dinoprostone; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Gene Knockdown Techniques; Genes, Reporter; Group IV Phospholipases A2; Hormone Antagonists; Humans; Hydrocortisone; Indomethacin; Ligands; Mifepristone; Progesterone; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; RNA, Small Interfering | 2010 |